Compare SMTI & MTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SMTI | MTRX |
|---|---|---|
| Founded | 1982 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Engineering & Construction |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 322.2M | 275.6M |
| IPO Year | 2008 | 1995 |
| Metric | SMTI | MTRX |
|---|---|---|
| Price | $33.26 | $10.03 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $35.00 | N/A |
| AVG Volume (30 Days) | 161.6K | ★ 518.5K |
| Earning Date | 11-11-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 91.51 |
| EPS | ★ N/A | N/A |
| Revenue | $15,586,976.00 | ★ $873,632,000.00 |
| Revenue This Year | $13.07 | $6.70 |
| Revenue Next Year | $14.23 | $5.71 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 32.47 | 13.56 |
| 52 Week Low | $16.05 | $9.38 |
| 52 Week High | $35.52 | $15.97 |
| Indicator | SMTI | MTRX |
|---|---|---|
| Relative Strength Index (RSI) | 23.14 | 44.91 |
| Support Level | $20.32 | $9.67 |
| Resistance Level | $34.36 | $10.84 |
| Average True Range (ATR) | 0.53 | 0.39 |
| MACD | -0.18 | 0.03 |
| Stochastic Oscillator | 57.42 | 47.60 |
Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.
Matrix Service Co provides engineering, fabrication, construction, and maintenance services supporting critical energy infrastructure and industrial markets. Its reportable segments are Storage and Terminal Solutions, Utility and Power Infrastructure, and Process and Industrial Facilities, with Storage and Terminal Solutions generating the maximum revenue. This segment provides integrated EPC, repair, maintenance, and fabrication services for bulk liquid, cryogenic, and refrigerated storage and terminal facilities supporting traditional and emerging energy markets, including LNG, NGLs, petroleum products, chemicals, hydrogen, and ammonia, and manufactures specialty tank products. The majority of revenue is generated from the United States.